Literature DB >> 3295

Measurement of 25-hydroxyvitamin D3 in serum.

R Bouillon, P V Kerkhove, P De Moor.   

Abstract

We describe a method for measuring 25-hydroxyvitamin D3 in serum. Extraction with dichloromethane/methanol (2/1 by vol), followed by chromatography on a column of Sephadex LH-20, resulted in an overall analytical recovery of 82% +/- 3.5% (SD). Diluted normal rat serum was used as binding protein because it contains a transport protein that has both a high affinity (Ka = 2 X 10(10) liter/mol) and a high capacity (3 X 10(-6) mol/liter) for 25-hydroxyvitamin D3. There is no advantage in using more complex binding proteins derived either from rachitic animals or from cytosol preparations. Concentrations of 25-hydroxyvitamin D3 (13.4 +/- 4 mug/liter) in the serum of apparently normal Belgian subjects are lower than those reported for North Americans, but resemble those reported for the United Kingdom.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 3295

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  24 in total

1.  Clinical chemistry through Clinical Chemistry: a journal timeline.

Authors:  Robert Rej
Journal:  Clin Chem       Date:  2004-12       Impact factor: 8.327

2.  1,25-Dihydroxycholecalciferol inhibits the cochemotactic activity of Gc (vitamin D binding protein).

Authors:  M Petrini; A Azzarà; G Carulli; B Grassi; F Ambrogi; R M Galbraith
Journal:  J Endocrinol Invest       Date:  1991-05       Impact factor: 4.256

3.  Serum concentrations of 25-hydroxy vitamin D in Europeans and Asians after oral vitamin D3.

Authors:  G Ellis; W T Cooke
Journal:  Br Med J       Date:  1978-03-18

4.  Parathyroid hormone secretion and 25-hydroxyvitamin D levels in primary osteoporosis.

Authors:  J Dequeker; R Bouillon
Journal:  Calcif Tissue Res       Date:  1977-05

5.  Mass fragmentographic determination of cholecalciferol and 25-hydroxycholecalciferol in human serum.

Authors:  B Zagalak; H C Curtius; R Foschi; G Wipf; U Redweik; M J Zagalak
Journal:  Experientia       Date:  1978-12-15

6.  Influence of indomethacin on extracellular calcium homeostasis.

Authors:  J W Bijlsma; A J Rabelink
Journal:  Ann Rheum Dis       Date:  1990-02       Impact factor: 19.103

7.  Autosomal dominant hypophosphataemia with elevated serum 1,25 dihydroxyvitamin D and hypercalciuria.

Authors:  W C Proesmans; G Fabry; G J Marchal; P L Gillis; R Bouillon
Journal:  Pediatr Nephrol       Date:  1987-07       Impact factor: 3.714

8.  The transport of vitamin D in the serum of primates.

Authors:  R Bouillon; H van Baelen; P de Moor
Journal:  Biochem J       Date:  1976-12-01       Impact factor: 3.857

9.  Short-term course of 1,25(OH)2D3 stimulates osteoblasts but not osteoclasts in osteoporosis and osteoarthritis.

Authors:  P Geusens; D Vanderschueren; A Verstraeten; J Dequeker; P Devos; R Bouillon
Journal:  Calcif Tissue Int       Date:  1991-09       Impact factor: 4.333

10.  Seasonal variation in bone metabolism in young healthy subjects.

Authors:  D Vanderschueren; G Gevers; J Dequeker; P Geusens; J Nijs; P Devos; M De Roo; R Bouillon
Journal:  Calcif Tissue Int       Date:  1991-08       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.